Revive Therapeutics Eulerpool Nyheter

Revive Therapeutics Aksje Nyheter

Revive Therapeutics blir fulgt av mange journalister og investorer over hele verden. De nyeste Revive Therapeutics nyhetene presenterer vi her.

• ·

  Yahoo
  Revive Therapeutics Advances with Next-Generation Bucillamine Development
• ·

  Yahoo
  Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
• ·

  Yahoo
  Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
• ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
• ·

  Yahoo
  Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
• ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
• ·

  Yahoo
  Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
• ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections
• ·

  Yahoo
  Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
• ·

  Yahoo
  Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product